GMP Training Online
Good Manufacturing Practice Course
(Annex 13)
person

GMP Online in Bulgarian | Good Manufacturing Practice Training Course

GMP - Good Manufacturing Practice (Annex 13) online training course for Investigational Medicinal Products in Bulgarian

This course provides grounding in the principles of Good Manufacturing Practice – specifically related to the manufacture of Investigational Medicinal Products (Annex 13). Applying GMP to IMPs provides assurance that results of clinical trials are not compromised by inadequate safety, quality or efficacy arising from unsatisfactory manufacture of product. It has many other benefits, including ensuring results are comparable across different batches of Investigational Medicinal Products. For the process to work, personnel must have an adequate training in requirements specific to Investigational Medicinal Products. The course is offered in Bulgarian.

  • Average study time:
    study time

    9 hrs

  • Personal development points (CPD):
    points

    9 points

  • Price:
    points

    £69.00

Please enter the number of licences required.

Course Details

  • Interactive with a clear, attractive format.
  • Ideal for those working with IMPs on clinical trials
  • Gain useful insights into the application of GMP from the author's professional experience.
  • Carries 9 CPD points.

Benefits for you

>>  Fully compliant

This course follows the guidance of Annex 13 of the European Commission's GMP guidelines - relating to Investigational Medicinal Products. Learners also receive 9 Continual Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.

>>  Certified

All learners who pass the final exam receive a uniquely numbered, personal certificate to demonstrate their subject knowledge. Since the questions are picked randomly from a database, re-sitting the exam doesn’t mean taking the same questions again and again.

>>  Affordable

Our cost-effective prices represent excellent value. You can easily pay up to ten-times more for face-to-face training.  We can also offer generous group discounts on larger purchases.

>>  Time-saving

Our new administration system makes it incredibly quick and simple to allocate licences to multiple learners. Learners save time too by choosing when and where they complete the training. Our reporting tools make it easy for administrators to check the progress of learners and identify areas for future training.

>>  Reliable and trustworthy

This course was written by McCarthy Consultant Services Inc (Canadian specialists in regulatory work to support the global pharmaceutical, biotechnology, medical device, food, natural health products and cosmetic industries). You will also stay up to date with any legislative changes in GMP relating to IMPs as our training courses are constantly monitored, reviewed and updated.

Course Syllabus

1. Изпитвани лекарствени продукти (ИЛП) 
1.1 Определение за ИЛП
1.2 По какъв начин ме касае Анекс 13? 
1.3 Защо е необходим Анекс 13, след като вече има ДПП?
1.4 Приложение на Анекс 13  
2. Общо протичане на процеса за ИЛП 
2.1 Възложителят
2.2 Производителят и опаковчикът
2.3 Квалифицираното лице
2.4 Превоз
2.5 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 1)
2.6  Получаване на ИЛП на мястото на клиничното проучване (Стъпка 2)
2.7 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 3)
2.8 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 4)
2.9 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 5)
2.10 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 6)
2.11 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 7)
2.12 Получаване на ИЛП на мястото на клиничното проучване (Стъпка 8)
2.13 Съхранение на ИЛП
2.14 Предписване
2.15 Работа с участници в клиничното проучване
2.16 Край на проучването
3. Оплаквания и анулиране 
3.1 Обработване на оплаквания
3.2 Анулиране
4. Заключение 
4.1 Окончателно заключение

 

Novartis logo                        NHS logo                        Takeda logo                        Roche logo                        DHL logo                        Baxter logo                        Quintiles logo                        King's College logo                        US AID logo                        Novo Nordisk logo                           Grunenthal logo                           Wellcome logo                           Ipsen logo                           BTG logo                           
  • 21,183 STUDENTS
  • 9,400 COMPANIES
  • 40 COUNTRIES
  • AND COUNTING.....